| | | | | Product | Package Size | EFP | CP | SB | DC | Composition | Registr. Holder | Category | | | | |
---|
What is an ATC-Code? | ATC-Overview |
|
| | IP | | | Cyclolux | 10 ml | 33.46 | 52.80 | 10 % | | Injection solution: Acidum Gadotericum 279.32 mg/ml | b.e.imaging.ag | B / SL / SG | FB | | G | |
| | IP | | | Cyclolux | 15 ml | 45.47 | 65.85 | 10 % | | Injection solution: Acidum Gadotericum 279.32 mg/ml | b.e.imaging.ag | B / SL / SG | FB | | G | |
| | IP | | | Cyclolux | 20 ml | 57.46 | 78.90 | 10 % | | Injection solution: Acidum Gadotericum 279.32 mg/ml | b.e.imaging.ag | B / SL / SG | FB | | G | |
L | | IP | | | Cyclolux | 60 ml | 160.63 | 189.45 | 10 % | | Injection solution: Acidum Gadotericum 279.32 mg/ml | b.e.imaging.ag | B / SL / SG | FB | | G | |
L | | IP | | | Cyclolux | 100 ml | 267.71 | 307.55 | 10 % | | Injection solution: Acidum Gadotericum 279.32 mg/ml | b.e.imaging.ag | B / SL / SG | FB | | G | |
| | IP | | | Dotarem | 10 ml | 47.80 | 67.50 | 10 % | | Injection solution: Acidum Gadotericum 279.3 mg/ml | Guerbet AG | B / SL / SO | FB | | G | |
| | IP | | | Dotarem | 10 ml | 47.80 | 67.50 | 10 % | | Injection solution: Acidum Gadotericum 279.3 mg/ml | Guerbet AG | B / SL / SO | FB | | G | |
| | IP | | | Dotarem | 15 ml | 64.96 | 85.85 | 10 % | | Injection solution: Acidum Gadotericum 279.3 mg/ml | Guerbet AG | B / SL / SO | FB | | G | |
| | IP | | | Dotarem | 15 ml | 64.96 | 85.85 | 10 % | | Injection solution: Acidum Gadotericum 279.3 mg/ml | Guerbet AG | B / SL / SO | FB | | G | |
| | IP | | | Dotarem | 20 ml | 82.09 | 104.20 | 10 % | | Injection solution: Acidum Gadotericum 279.3 mg/ml | Guerbet AG | B / SL / SO | FB | | G | |
| | IP | | | Dotarem | 20 ml | 82.09 | 104.20 | 10 % | | Injection solution: Acidum Gadotericum 279.3 mg/ml | Guerbet AG | B / SL / SO | FB | | G | |
L | | IP | | | Dotarem | 60 ml | 246.27 | 277.35 | 10 % | | Injection solution: Acidum Gadotericum 279.3 mg/ml | Guerbet AG | B / SL / SO | FB | | G | |
| | IP | | | Clariscan | 10 ml | 33.46 | 52.80 | 10 % | | Injection solution: Acidum Gadotericum 279.3 mg/ml | GE Healthcare AG | B / SL / SG | FB | | G | |
| | IP | | | Clariscan | 10 ml | 33.46 | 52.80 | 10 % | | Injection solution: Acidum Gadotericum 279.3 mg/ml | GE Healthcare AG | B / SL / SG | FB | | G | |
| | IP | | | Clariscan | 15 ml | 45.47 | 65.85 | 10 % | | Injection solution: Acidum Gadotericum 279.3 mg/ml | GE Healthcare AG | B / SL / SG | FB | | G | |
| | IP | | | Clariscan | 15 ml | 45.47 | 65.85 | 10 % | | Injection solution: Acidum Gadotericum 279.3 mg/ml | GE Healthcare AG | B / SL / SG | FB | | G | |
| | IP | | | Clariscan | 20 ml | 57.46 | 78.90 | 10 % | | Injection solution: Acidum Gadotericum 279.3 mg/ml | GE Healthcare AG | B / SL / SG | FB | | G | |
| | IP | | | Clariscan | 20 ml | 57.46 | 78.90 | 10 % | | Injection solution: Acidum Gadotericum 279.3 mg/ml | GE Healthcare AG | B / SL / SG | FB | | G | |
| | IP | | | Clariscan | 50 ml | 133.86 | 162.00 | 10 % | | Injection solution: Acidum Gadotericum 279.3 mg/ml | GE Healthcare AG | B / SL / SG | FB | | G | |
| | IP | | | Clariscan | 100 ml | 267.71 | 307.55 | 10 % | | Injection solution: Acidum Gadotericum 279.3 mg/ml | GE Healthcare AG | B / SL / SG | FB | | G | |
| | IP | | | Artirem | Durchstechflasche(n) à 20 ml | 43.02 | 63.20 | 10 % | | Injection solution: Acidum Gadotericum 1.397 mg/ml | Guerbet AG | B / SL | FB | | G | |
| | IP | | | Artirem | syringe(s) à 20 ml | 50.12 | 74.00 | k.A. | | Injection solution: Acidum Gadotericum 1.397 mg/ml | Guerbet AG | B | FB | | G | |
| | IP | | | Clariscan | 50 ml | PR | PR | k.A. | | Injection solution: Acidum Gadotericum 279.3 mg/ml | GE Healthcare AG | B | FB | | G | |
| | IP | | | Clariscan | 60 ml | PR | PR | k.A. | | Injection solution: Acidum Gadotericum 279.3 mg/ml | GE Healthcare AG | B | FB | | G | |
|
| | IP | | | Omniscan | 10 ml | 51.57 | 72.50 | k.A. | | Injection solution: Gadodiamidum 287 mg | GE Healthcare AG | B | FB | | G | |
| | IP | | | Omniscan | 10 ml | 51.57 | 72.50 | k.A. | | Injection solution: Gadodiamidum 287 mg | GE Healthcare AG | B | FB | | G | |
| | IP | | | Omniscan | 15 ml | 78.61 | 101.90 | k.A. | | Injection solution: Gadodiamidum 287 mg | GE Healthcare AG | B | FB | | G | |
| | IP | | | Omniscan | 15 ml | 77.79 | 101.00 | k.A. | | Injection solution: Gadodiamidum 287 mg | GE Healthcare AG | B | FB | | G | |
| | IP | | | Omniscan | 20 ml | 101.72 | 127.05 | k.A. | | Injection solution: Gadodiamidum 287 mg | GE Healthcare AG | B | FB | | G | |
| | IP | | | Omniscan | 20 ml | 97.67 | 122.65 | k.A. | | Injection solution: Gadodiamidum 287 mg | GE Healthcare AG | B | FB | | G | |
| | IP | | | Omniscan | 50 ml | PR | PR | k.A. | | Injection solution: Gadodiamidum 287 mg | GE Healthcare AG | B | FB | | G | |
| | IP | | | Omniscan | 10 x 10 ml | PR | PR | k.A. | | Injection solution: Gadodiamidum 287 mg | GE Healthcare AG | B | FB | | G | |
| | IP | | | Omniscan | 10 x 10 ml | PR | PR | k.A. | | Injection solution: Gadodiamidum 287 mg | GE Healthcare AG | B | FB | | G | |
| | IP | | | Omniscan | 100 ml | PR | PR | k.A. | | Injection solution: Gadodiamidum 287 mg | GE Healthcare AG | B | FB | | G | |
| | IP | | | Omniscan | 10 x 15 ml | PR | PR | k.A. | | Injection solution: Gadodiamidum 287 mg | GE Healthcare AG | B | FB | | G | |
| | IP | | | Omniscan | 10 x 15 ml | PR | PR | k.A. | | Injection solution: Gadodiamidum 287 mg | GE Healthcare AG | B | FB | | G | |
| | IP | | | Omniscan | 10 x 20 ml | PR | PR | k.A. | | Injection solution: Gadodiamidum 287 mg | GE Healthcare AG | B | FB | | G | |
| | IP | | | Omniscan | 10 x 20 ml | PR | PR | k.A. | | Injection solution: Gadodiamidum 287 mg | GE Healthcare AG | B | FB | | G | |
| | IP | | | Omniscan | 10 x 50 ml | PR | PR | k.A. | | Injection solution: Gadodiamidum 287 mg | GE Healthcare AG | B | FB | | G | |
| | IP | | | Omniscan | 10 x 100 ml | PR | PR | k.A. | | Injection solution: Gadodiamidum 287 mg | GE Healthcare AG | B | FB | | G | |
|
| | IP | | | ProHance 0.5 mmol/ml | Flasche(n) à 10 ml | 46.68 | 67.20 | 10 % | | soluzione iniettabile (flacone): Gadoteridolum 279.3 mg | Bracco Suisse SA | B / SL | FB | | G | |
| | IP | | | ProHance 0.5 mmol/ml | Flasche(n) à 15 ml | 65.89 | 88.10 | 10 % | | soluzione iniettabile (flacone): Gadoteridolum 279.3 mg | Bracco Suisse SA | B / SL | FB | | G | |
| | IP | | | ProHance 0.5 mmol/ml | Flasche(n) à 20 ml | 85.28 | 109.15 | 10 % | | soluzione iniettabile (flacone): Gadoteridolum 279.3 mg | Bracco Suisse SA | B / SL | FB | | G | |
| | IP | | | ProHance 0.5 mmol/ml | Flasche(n) à 50 ml | 216.74 | 252.15 | 10 % | | soluzione iniettabile (flacone): Gadoteridolum 279.3 mg | Bracco Suisse SA | B / SL | FB | | G | |
| | IP | | | ProHance 0.5 mmol/ml | 10 ml | 46.68 | 67.20 | 10 % | | soluzione iniettabile (siringa di iniezione preriempita): Gadoteridolum 279.3 mg | Bracco Suisse SA | B / SL | FB | | G | |
| | IP | | | ProHance 0.5 mmol/ml | 17 ml | 74.53 | 97.45 | 10 % | | soluzione iniettabile (siringa di iniezione preriempita): Gadoteridolum 279.3 mg | Bracco Suisse SA | B / SL | FB | | G | |
| | IP | | | ProHance 0.5 mmol/ml | Flasche(n) à 5 ml | 27.63 | 48.10 | k.A. | | soluzione iniettabile (flacone): Gadoteridolum 279.3 mg | Bracco Suisse SA | B | FB | | G | |
| | IP | | | ProHance 0.5 mmol/ml | 5 1 Flasche(n) à 5 ml | PR | PR | k.A. | | soluzione iniettabile (flacone): Gadoteridolum 279.3 mg | Bracco Suisse SA | B | FB | | G | |
| | IP | | | ProHance 0.5 mmol/ml | 10 1 Flasche(n) à 5 ml | PR | PR | k.A. | | soluzione iniettabile (flacone): Gadoteridolum 279.3 mg | Bracco Suisse SA | B | FB | | G | |
| | IP | | | ProHance 0.5 mmol/ml | 5 1 Flasche(n) à 10 ml | PR | PR | k.A. | | soluzione iniettabile (flacone): Gadoteridolum 279.3 mg | Bracco Suisse SA | B | FB | | G | |
| | IP | | | ProHance 0.5 mmol/ml | 5 1 Flasche(n) à 15 ml | PR | PR | k.A. | | soluzione iniettabile (flacone): Gadoteridolum 279.3 mg | Bracco Suisse SA | B | FB | | G | |
| | IP | | | ProHance 0.5 mmol/ml | 20 1 Flasche(n) à 5 ml | PR | PR | k.A. | | soluzione iniettabile (flacone): Gadoteridolum 279.3 mg | Bracco Suisse SA | B | FB | | G | |
| | IP | | | ProHance 0.5 mmol/ml | 10 1 Flasche(n) à 10 ml | PR | PR | k.A. | | soluzione iniettabile (flacone): Gadoteridolum 279.3 mg | Bracco Suisse SA | B | FB | | G | |
| | IP | | | ProHance 0.5 mmol/ml | 5 1 Flasche(n) à 20 ml | PR | PR | k.A. | | soluzione iniettabile (flacone): Gadoteridolum 279.3 mg | Bracco Suisse SA | B | FB | | G | |
| | IP | | | ProHance 0.5 mmol/ml | 10 1 Flasche(n) à 15 ml | PR | PR | k.A. | | soluzione iniettabile (flacone): Gadoteridolum 279.3 mg | Bracco Suisse SA | B | FB | | G | |
| | IP | | | ProHance 0.5 mmol/ml | 20 1 Flasche(n) à 10 ml | PR | PR | k.A. | | soluzione iniettabile (flacone): Gadoteridolum 279.3 mg | Bracco Suisse SA | B | FB | | G | |
| | IP | | | ProHance 0.5 mmol/ml | 10 1 Flasche(n) à 20 ml | PR | PR | k.A. | | soluzione iniettabile (flacone): Gadoteridolum 279.3 mg | Bracco Suisse SA | B | FB | | G | |
| | IP | | | ProHance 0.5 mmol/ml | 20 1 Flasche(n) à 15 ml | PR | PR | k.A. | | soluzione iniettabile (flacone): Gadoteridolum 279.3 mg | Bracco Suisse SA | B | FB | | G | |
| | IP | | | ProHance 0.5 mmol/ml | 20 1 Flasche(n) à 20 ml | PR | PR | k.A. | | soluzione iniettabile (flacone): Gadoteridolum 279.3 mg | Bracco Suisse SA | B | FB | | G | |
| | IP | | | ProHance 0.5 mmol/ml | 10 1 Flasche(n) à 50 ml | PR | PR | k.A. | | soluzione iniettabile (flacone): Gadoteridolum 279.3 mg | Bracco Suisse SA | B | FB | | G | |
| | IP | | | ProHance 0.5 mmol/ml | 15 ml | PR | PR | k.A. | | soluzione iniettabile (siringa di iniezione preriempita): Gadoteridolum 279.3 mg | Bracco Suisse SA | B | FB | | G | |
| | IP | | | ProHance 0.5 mmol/ml | 5 x 10 ml | PR | PR | k.A. | | soluzione iniettabile (siringa di iniezione preriempita): Gadoteridolum 279.3 mg | Bracco Suisse SA | B | FB | | G | |
| | IP | | | ProHance 0.5 mmol/ml | 5 x 15 ml | PR | PR | k.A. | | soluzione iniettabile (siringa di iniezione preriempita): Gadoteridolum 279.3 mg | Bracco Suisse SA | B | FB | | G | |
| | IP | | | ProHance 0.5 mmol/ml | 5 x 17 ml | PR | PR | k.A. | | soluzione iniettabile (siringa di iniezione preriempita): Gadoteridolum 279.3 mg | Bracco Suisse SA | B | FB | | G | |
|
| | IP | | | Gadovist 1,0 | 2 ml | 14.02 | 31.65 | 10 % | | Injection solution: Gadobutrolum 604.72 mg | Bayer (Schweiz) AG | B / SL | FB | | G | |
| | IP | | | Gadovist 1,0 | syringe(s) à 5 ml | 48.29 | 68.95 | 10 % | | Injection solution: Gadobutrolum 604.72 mg | Bayer (Schweiz) AG | B / SL | FB | | G | |
| | IP | | | Gadovist 1,0 | syringe(s) à 7.5 ml | 72.43 | 95.20 | 10 % | | Injection solution: Gadobutrolum 604.72 mg | Bayer (Schweiz) AG | B / SL | FB | | G | |
| | IP | | | Gadovist 1,0 | syringe(s) à 10 ml | 82.09 | 105.70 | 10 % | | Injection solution: Gadobutrolum 604.72 mg | Bayer (Schweiz) AG | B / SL | FB | | G | |
| | IP | | | Gadovist 1,0 | syringe(s) à 15 ml | 131.28 | 159.20 | 10 % | | Injection solution: Gadobutrolum 604.72 mg | Bayer (Schweiz) AG | B / SL | FB | | G | |
| | IP | | | Gadovist 1,0 | piece(s) à 15 ml | 131.28 | 159.20 | 10 % | | Injection solution: Gadobutrolum 604.72 mg | Bayer (Schweiz) AG | B / SL | FB | | G | |
| | IP | | | Gadovist 1,0 | Flasche(n) à 30 ml | 210.42 | 245.25 | 10 % | | Injection solution: Gadobutrolum 604.72 mg | Bayer (Schweiz) AG | B / SL | FB | | G | |
L | | IP | | | Gadovist 1,0 | Flasche(n) à 65 ml | 434.47 | 488.95 | 10 % | | Injection solution: Gadobutrolum 604.72 mg | Bayer (Schweiz) AG | B / SL | FB | | G | |
| | IP | | | Gadovist 1,0 | syringe(s) à 5 ml | PR | PR | k.A. | | Injection solution: Gadobutrolum 604.72 mg | Bayer (Schweiz) AG | B | FB | | G | |
| | IP | | | Gadovist 1,0 | syringe(s) à 7.5 ml | PR | PR | k.A. | | Injection solution: Gadobutrolum 604.72 mg | Bayer (Schweiz) AG | B | FB | | G | |
| | IP | | | Gadovist 1,0 | syringe(s) à 10 ml | PR | PR | k.A. | | Injection solution: Gadobutrolum 604.72 mg | Bayer (Schweiz) AG | B | FB | | G | |
| | IP | | | Gadovist 1,0 | syringe(s) à 15 ml | PR | PR | k.A. | | Injection solution: Gadobutrolum 604.72 mg | Bayer (Schweiz) AG | B | FB | | G | |
|
| SIP | IP | | | Primovist 0.25 mmol/ml | syringe(s) | 173.27 | 204.85 | 10 % | | Injection solution: Dinatrii Gadoxetas 181.43 mg/ml | Bayer (Schweiz) AG | B / SL | FB | | G | |
| SIP | IP | | | Primovist 0.25 mmol/ml | | PR | PR | k.A. | | Injection solution: Dinatrii Gadoxetas 181.43 mg/ml | Bayer (Schweiz) AG | B | FB | | G | |
|
| | IP | | | Elucirem 0.5 mmol/ml | 3 ml | PR | PR | k.A. | | | Guerbet AG | B | FB | | G | |
| | IP | | | Elucirem 0.5 mmol/ml | 7.5 ml | PR | PR | k.A. | | | Guerbet AG | B | FB | | G | |
| | IP | | | Elucirem 0.5 mmol/ml | 7.5 ml | PR | PR | k.A. | | | Guerbet AG | B | FB | | G | |
| | IP | | | Elucirem 0.5 mmol/ml | 10 ml | PR | PR | k.A. | | | Guerbet AG | B | FB | | G | |
| | IP | | | Elucirem 0.5 mmol/ml | 10 ml | PR | PR | k.A. | | | Guerbet AG | B | FB | | G | |
| | IP | | | Elucirem 0.5 mmol/ml | 15 ml | PR | PR | k.A. | | | Guerbet AG | B | FB | | G | |
| | IP | | | Elucirem 0.5 mmol/ml | 30 ml | PR | PR | k.A. | | | Guerbet AG | B | FB | | G | |
| | | | CM | Vueway | 3 ml | PR | PR | k.A. | | | Bracco Suisse SA | B | FB | | G | |
| | | | CM | Vueway | 7.5 ml | PR | PR | k.A. | | | Bracco Suisse SA | B | FB | | G | |
| | | | CM | Vueway | 7.5 ml | PR | PR | k.A. | | | Bracco Suisse SA | B | FB | | G | |
| | | | CM | Vueway | 10 ml | PR | PR | k.A. | | | Bracco Suisse SA | B | FB | | G | |
| | | | CM | Vueway | 15 ml | PR | PR | k.A. | | | Bracco Suisse SA | B | FB | | G | |
| | | | CM | Vueway | 30 ml | PR | PR | k.A. | | | Bracco Suisse SA | B | FB | | G | |